Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robohogs who wrote (10060)	5/9/2007 3:01:10 AM
From: Robohogs	Read Replies (1) of 10280

Can find no info on Brovana. Sorry. Did see updated info on Xop HFA in graph form - no hard data sorry on shares etc. but from graph, TRx in mkt for albuterol mdi's has declined from ~850K to about ~775K over last 4 weeks or so. Looks seasonal so nothing to worry about. Most of decline has come from ProAir from Teva (down about 60-75K), maybe a very slight decline in CFC devices (gaining back some share though), with Xop HFA flat along with Proventil. On hard data front, current four week runrates for Xop HFA are 225K, flat to a month ago. Ventolin (GSK) is up from 45K to 53K. Proventil is down to 309K from 314K. ProAir is down from 1215K to 1103K. And generics are off about 100K. On share front, CFCs are up about 3-5% over last week or two (down over last month but up ~5% over last month and a half), ProAir is off 10% of share points over last month and a half, with Xop and Proventil flat and Ventolin up a bit. Jon

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next